Dr. Reddy's Defeat Of FCA Case Offers 'Guidepost' For Litigation After Escobar
Executive Summary
Dismissal of False Claims Act suit against Dr. Reddy's shows impact of US Supreme Court's Escobar decision. Government FCA pharma recoveries shot up 58% from 2015 to 2016; graphic breaks out settlements by kickback, off-label promotion and improper billing cases.